Cargando…
Effect of age as a continuous variable on survival outcomes and treatment selection in patients with extranodal nasal-type NK/T-cell lymphoma from the China Lymphoma Collaborative Group (CLCG)
Purpose: The aim of this study was to determine the impact of analyzing age as a continuous variable on survival outcomes and treatment selection for extranodal nasal-type NK/T-cell lymphoma. Results: The risk of mortality increased with increasing age, without an apparent cutoff point. Patients’ ag...
Autores principales: | Liu, Wei-Xin, Shi, Mei, Su, Hang, Wang, Ying, He, Xia, Xu, Li-Ming, Yuan, Zhi-Yong, Zhang, Li-Ling, Wu, Gang, Qu, Bao-Lin, Qian, Li-Ting, Hou, Xiao-Rong, Zhang, Fu-Quan, Zhang, Yu-Jing, Zhu, Yuan, Cao, Jian-Zhong, Lan, Sheng-Min, Wu, Jun-Xin, Wu, Tao, Zhu, Su-Yu, Qi, Shu-Nan, Yang, Yong, Chen, Bo, Li, Ye-Xiong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6814612/ https://www.ncbi.nlm.nih.gov/pubmed/31586991 http://dx.doi.org/10.18632/aging.102331 |
Ejemplares similares
-
Risk‐dependent curability of radiotherapy for elderly patients with early‐stage extranodal nasal‐type NK/T‐cell lymphoma: A multicenter study from the China Lymphoma Collaborative Group (CLCG)
por: Chen, Bo, et al.
Publicado: (2018) -
Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study
por: Yang, Yong, et al.
Publicado: (2020) -
Evidence of cure for extranodal nasal-type natural killer/T-cell lymphoma with current treatment: an analysis of the CLCG database
por: Liu, Xin, et al.
Publicado: (2023) -
Outcome and risk prediction of early progression in patients with extranodal natural killer/T cell lymphoma from the CLCG study
por: Li, Jia-Ying, et al.
Publicado: (2023) -
Association of improved overall survival with decreased distant metastasis following asparaginase-based chemotherapy and radiotherapy for intermediate- and high-risk early-stage extranodal nasal-type NK/T-cell lymphoma: a CLCG study
por: Zheng, X., et al.
Publicado: (2021)